WallStSmart

Cboe Global Markets Inc (CBOE)vsCME Group Inc (CME)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 41% more annual revenue ($6.74B vs $4.79B). CME leads profitability with a 63.3% profit margin vs 25.8%. CBOE appears more attractively valued with a PEG of 2.13. CBOE earns a higher WallStSmart Score of 70/100 (B-).

CBOE

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 9.0Value: 5.0Quality: 8.5
Piotroski: 4/9Altman Z: 2.58

CME

Buy

65

out of 100

Grade: C+

Growth: 6.7Profit: 8.0Value: 4.3Quality: 5.0
Piotroski: 2/9Altman Z: 0.30

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CBOE5 strengths · Avg: 9.4/10
Operating MarginProfitability
39.7%10/10

Strong operational efficiency at 39.7%

EPS GrowthGrowth
54.4%10/10

Earnings expanding 54.4% YoY

Return on EquityProfitability
23.0%9/10

Every $100 of equity generates 23 in profit

Profit MarginProfitability
25.8%9/10

Keeps 26 of every $100 in revenue as profit

Debt/EquityHealth
0.299/10

Conservative balance sheet, low leverage

CME6 strengths · Avg: 9.0/10
Profit MarginProfitability
63.3%10/10

Keeps 63 of every $100 in revenue as profit

Operating MarginProfitability
69.8%10/10

Strong operational efficiency at 69.8%

Market CapQuality
$90.52B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

EPS GrowthGrowth
21.3%8/10

Earnings expanding 21.3% YoY

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

Areas to Watch

CBOE2 concerns · Avg: 4.0/10
PEG RatioValuation
2.134/10

Expensive relative to growth rate

P/E RatioValuation
25.2x4/10

Moderate valuation

CME3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
4.522/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.302/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CBOE

The strongest argument for CBOE centers on Operating Margin, EPS Growth, Return on Equity. Profitability is solid with margins at 25.8% and operating margin at 39.7%.

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.3% and operating margin at 69.8%. Revenue growth of 14.4% demonstrates continued momentum.

Bear Case : CBOE

The primary concerns for CBOE are PEG Ratio, P/E Ratio.

Bear Case : CME

The primary concerns for CME are Piotroski F-Score, PEG Ratio, Altman Z-Score.

Key Dynamics to Monitor

CBOE carries more volatility with a beta of 0.40 — expect wider price swings.

CME is growing revenue faster at 14.4% — sustainability is the question.

CME generates stronger free cash flow (1.2B), providing more financial flexibility.

Monitor FINANCIAL DATA & STOCK EXCHANGES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CBOE scores higher overall (70/100 vs 65/100), backed by strong 25.8% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cboe Global Markets Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

Cboe Global Markets is an American company that owns the Chicago Board Options Exchange and the stock exchange operator BATS Global Markets.

Visit Website →

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

Want to dig deeper into these stocks?